Ameritas Investment Partners, Inc. - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$59,052
+17.3%
6,475
+36.1%
0.00%0.0%
Q2 2023$50,350
-13.5%
4,7590.0%0.00%0.0%
Q1 2023$58,203
-12.5%
4,7590.0%0.00%
-33.3%
Q4 2022$66,483
+2.3%
4,7590.0%0.00%0.0%
Q3 2022$65,000
-25.3%
4,7590.0%0.00%
-25.0%
Q2 2022$87,000
+3.6%
4,759
-9.3%
0.00%
+33.3%
Q1 2022$84,000
+15.1%
5,2460.0%0.00%
+50.0%
Q4 2021$73,000
-25.5%
5,2460.0%0.00%
-50.0%
Q3 2021$98,000
-10.1%
5,2460.0%0.00%0.0%
Q2 2021$109,000
-26.4%
5,2460.0%0.00%
-33.3%
Q1 2021$148,000
-13.5%
5,2460.0%0.01%
-25.0%
Q4 2020$171,000
+18.8%
5,246
+12.0%
0.01%
+14.3%
Q3 2020$144,000
+89.5%
4,6860.0%0.01%
+75.0%
Q2 2020$76,000
+171.4%
4,686
+64.2%
0.00%
+100.0%
Q1 2020$28,000
-28.2%
2,8530.0%0.00%0.0%
Q4 2019$39,000
-9.3%
2,8530.0%0.00%0.0%
Q3 2019$43,000
-6.5%
2,853
+21.4%
0.00%0.0%
Q2 2019$46,000
+17.9%
2,3500.0%0.00%0.0%
Q1 2019$39,000
+18.2%
2,3500.0%0.00%0.0%
Q4 2018$33,000
+10.0%
2,350
+36.6%
0.00%
+100.0%
Q3 2018$30,000
-3.2%
1,7200.0%0.00%0.0%
Q2 2018$31,000
-3.1%
1,7200.0%0.00%
-50.0%
Q1 2018$32,000
+68.4%
1,720
+37.4%
0.00%
+100.0%
Q4 2017$19,000
+111.1%
1,2520.0%0.00%
Q3 2017$9,000
-25.0%
1,2520.0%0.00%
-100.0%
Q2 2017$12,0001,2520.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders